High Pesticide Exposure Events and Olfactory Dysfunction: Integrating Subjective and Objective Evidence from Agricultural Cohorts

High Pesticide Exposure Events and Olfactory Dysfunction: Integrating Subjective and Objective Evidence from Agricultural Cohorts

Emerging evidence links high pesticide exposure events (HPEEs) in farmers to increased self-reported olfactory dysfunction, though objective smell testing yields inconclusive associations, highlighting critical gaps and methodological considerations in assessing pesticide-related olfactory impairment.
Differentiating Persistent and Recurrent Dysphagia After Surgery for Cricopharyngeal Muscle Dysfunction with Zenker Diverticulum: Insights from the POuCH Study

Differentiating Persistent and Recurrent Dysphagia After Surgery for Cricopharyngeal Muscle Dysfunction with Zenker Diverticulum: Insights from the POuCH Study

The POuCH study clarifies outcomes of surgery for cricopharyngeal muscle dysfunction (CPMD) with Zenker diverticulum, distinguishing persistent from recurrent dysphagia via patient-reported EAT-10 scores, aiding clinical management of postoperative swallowing difficulties.
Compartment-Specific Nodal Recurrence in Medullary Thyroid Cancer: Evaluating the Role of Contralateral Prophylactic Central Neck Dissection

Compartment-Specific Nodal Recurrence in Medullary Thyroid Cancer: Evaluating the Role of Contralateral Prophylactic Central Neck Dissection

This multicenter study assesses recurrence patterns in medullary thyroid cancer, finding ipsilateral neck sites are the most common recurrence locations, with limited evidence supporting routine contralateral prophylactic central neck dissection in clinically node-negative patients.
Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort

Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort

This study investigates the association between peri- and post-menopausal hormone replacement therapy (HRT) and the risk of voice disorders, revealing transiently increased dysphonia risk within the first nine months but no sustained clinical impact after one year.